Options & Mergers Analyst Glick, Pharmaceuticals Analyst Scala and Biotech Analyst Werber review the Prometheus Biosciences and Merck deal on an Analyst/Industry Webinar to be held on April 21 at 10:30. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RXDX:
- Biotech Alert: Searches spiking for these stocks today
- Prometheus downgraded to Equal Weight from Overweight at Wells Fargo
- Prometheus downgraded to Sector Perform from Outperform at RBC Capital
- Prometheus downgraded to Neutral from Outperform at Credit Suisse
- Prometheus downgraded to Neutral from Overweight at Piper Sandler
